Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 2.

Health Canada approves Kevzara antibody to treat patients with rheumatoid arthritis
Sanofi has received approval from Health Canada for Kevzara (sarilumab), an interleukin-6 (IL-6) receptor antibody, to treat adult patients with moderately to severely active rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 2, 2017 Category: Pharmaceuticals Source Type: news

Drug combination effective against chikungunya arthritis in mice
Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the earliest stage of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Discovery of new T-cell subtype opens window on rheumatoid arthritis
Researchers have carefully scrutinized the immune cells from patients with rheumatoid arthritis, revealing a striking new subset of T-cells that collaborate with other immune cells to drive inflammation in peripheral tissues. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 1, 2017 Category: Science Source Type: news

Use of Biologic Therapy in Racial Minorities With RA Use of Biologic Therapy in Racial Minorities With RA
A new study investigates possible racial and ethnic disparities in the access and administration of biologic agents for rheumatoid arthritis. Are there discrepancies?Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Drug combination effective against chikungunya arthritis in mice
(Washington University School of Medicine) Chikungunya virus causes a painful, debilitating arthritis for which there is currently no treatment. A new study has found that combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the earliest stage of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 1, 2017 Category: Infectious Diseases Source Type: news

Discovery of New T-Cell Subtype Opens Window on Rheumatoid Arthritis
Finding flows from researchers ’ use of high-tech tools to deeply and efficiently characterize patient cells (Source: BWH News)
Source: BWH News - February 1, 2017 Category: Hospital Management Source Type: news

Discovery of New T-Cell Subtype Opens Window on Rheumatoid Arthritis
Finding flows from researchers ’ use of high-tech tools to deeply and efficiently characterize patient cells (Source: BWH for Journalists)
Source: BWH for Journalists - February 1, 2017 Category: Research Source Type: news

Post-Test on Rheumatoid Arthritis in Primary Care
Use this short test to gauge how much you ’ve learned about a condition that needs more primary care involvement. (Source: ConsultantLive)
Source: ConsultantLive - January 30, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Quiz Special Report Source Type: news

Medical News Today: Natural Remedies for Rheumatoid Arthritis
Can a diet change and other lifestyle changes help reduce discomfort caused by rheumatoid arthritis? Learn about other natural remedies that may help. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Adalimumab Biosimilar Candidate Recommended for EMA Approval THOUSAND OAKS, Calif., Jan. 27, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 501 (biosimilar adalimumab), recommending approval for all available indications. ABP 501 has been recommended for approval for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis (AS), se...
Source: Amgen News Release - January 27, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Immune cell study sheds new light on how inflammatory arthritis begins
This study, published in the medical journal Science Immunology, used multiphoton intravital microscopy - an imaging technology that allows immune cell movements to be tracked in real time - to follow the development of arthritis in lab mice withrheumatoid arthritis, in order to better understand how this works. It was revealed that the presence of immune complexes within the joint space leads to the production of a molecule called C5a, which is then displayed on the inner walls of adjacent blood vessels and causes immune cells called neutrophils to pass into the joint, setting off the process of inflammation. The implicat...
Source: Arthritis Research UK - January 25, 2017 Category: Rheumatology Source Type: news

Psoriatic Disease Tied to Elevated Fracture Risk Psoriatic Disease Tied to Elevated Fracture Risk
Patients with psoriatic arthritis and psoriasis may have the same increased risk for fracture as those with rheumatoid arthritis, according to a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Roche says FDA grants priority review for Actemra
ZURICH (Reuters) - The U.S. Food and Drug Administration (FDA) has granted priority review designation of Roche's rheumatoid arthritis medication Actemra for giant cell arteritis (GCA), the Swiss drugmaker said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - January 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Scripps Florida team awarded $1.8 million grant to develop drugs for heart disease and rheumatoid ar
(Scripps Research Institute) Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2017 Category: Global & Universal Source Type: news

Q & A: A Scientific Lens on Copper
Copper bracelets and other folk remedies, like magnetic straps, were no more effective against arthritis than a placebo, a study found. (Source: NYT Health)
Source: NYT Health - January 23, 2017 Category: Consumer Health News Authors: C. CLAIBORNE RAY Tags: Rheumatoid Arthritis Copper, Brass and Bronze Public Library of Science (PLoS) Source Type: news

8 New Rheumatoid Arthritis Findings
RA symptoms invisible but harmful, mortality increases with RA, plus 6 more highlights from recent RA studies of interest to primary care. (Source: ConsultantLive)
Source: ConsultantLive - January 22, 2017 Category: Internal Medicine Authors: Leo Robert Tags: Special Report Musculoskeletal Disorders Source Type: news

Empowering patients to be their own personal trainers to improve function and strength - Implementing NICE CG79
The programme demonstrates the implementation of NICE guideline CG79 for management of rheumatoid arthritis in adults. It specifically relates to the delivery of recommendations that patients should have access to specialist physiotherapy, with periodic review. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 20, 2017 Category: Consumer Health News Source Type: news

Biosimilars: Bringing Patients into the Conversation
There ’s no doubt that the cheaper cost of biosimilars versus their originator biologic, even though not as substantial as generics, make them very attractive to healthcare markets. But so far, biosimilar manufacturers have dedicated most of their efforts to convincing payers of thesecost benefits, seeing them as the primary gatekeeper of market access. However, by focusing just on payers, are they missing a trick? In the longer-term, manufacturers could benefit from educating and winning over a wider audience, and not justphysicians, but also patients.Cheaper prices should lead to greater access to biologic therapy, esp...
Source: EyeForPharma - January 20, 2017 Category: Pharmaceuticals Authors: Mariel Metcalfe Source Type: news

Rheumatoid Arthritis: 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis: 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications
Title: Rheumatoid Arthritis (RA): 17 Warning Signs of Serious ComplicationsCategory: Doctor's& Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

Living With Rheumatoid Arthritis
Title: Living With Rheumatoid ArthritisCategory: Doctor's& Expert's views on SymptomsCreated: 8/9/2006 12:00:00 AMLast Editorial Review: 1/20/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 20, 2017 Category: Rheumatology Source Type: news

MedImmune gets OK from China to pursue arthritis drug in joint venture deal
Gaithersburg-based MedImmune is expanding its footprint in China's drug market after receiving a permit to begin clinical trials there on a biologic therapy for rheumatoid arthritis. MedImmune, which is the R&D arm for London-based AstraZeneca (NYSE: AZN) drug giant AstraZeneca, produced the biologic in a joint venture with leading Chinese biologics manufacturer WuXi AppTech. This is the first collaboration of its kind between an multinational pharmaceutical corporation and a Chinese company, said… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 19, 2017 Category: American Health Authors: Tina Reed Source Type: news

Early Diagnosis of Rheumatoid Arthritis in Primary Care
Primary care physicians may contribute to improved outcomes by recognizing the signs and symptoms early on. Part 2 of a Special Report. (Source: ConsultantLive)
Source: ConsultantLive - January 17, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Rheumatoid Arthritis
(RA) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 17, 2017 Category: Journals (General) Source Type: news

US FDA extends review period for Eli Lilly and Incyte ’s rheumatoid arthritis treatment
The US Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA) for Eli Lilly and Incyte ’s investigational baricitinib used to treat patients suffering from moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - January 16, 2017 Category: Pharmaceuticals Source Type: news

U.S. FDA Extends Review Period For Baricitinib, An Investigational Rheumatoid Arthritis Treatment
INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the new drug application (NDA)... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 13, 2017 Category: Drugs & Pharmacology Source Type: news

Rheumatoid Arthritis: Mortality Gap Narrows Rheumatoid Arthritis: Mortality Gap Narrows
Post-2000 treat-to-target regimens may underlie a drop in relative 5-year all-cause, cardiovascular, and cancer deaths among patients with early RA vs those in the general population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)
Title: Ultrasound Imaging of Joints in Rheumatoid Arthritis (RA)Category: Doctor's& Expert's views on SymptomsCreated: 2/6/2001 12:00:00 AMLast Editorial Review: 1/11/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 11, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis in Primary Care
This Special Report details the expanding role PCPs can play in serving an increasingly underserved population. (Source: ConsultantLive)
Source: ConsultantLive - January 9, 2017 Category: Internal Medicine Authors: Kevin D. Deane, MD, PhD Sarah Dill, MD Tags: Special Report Musculoskeletal Disorders Source Type: news

Pfizer reports positive top-line data from REFLECTIONS B538-02 study of PF-06410293
Pfizer has reported positive top-line data from its REFLECTIONS B538-02 study of PF-06410293 compared with Humira to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - January 9, 2017 Category: Pharmaceuticals Source Type: news

How BPA Exposure Lowers Vitamin D Levels
What do breast cancer, ADHD, diabetes, male fertility and autism have in common? They're very different conditions, but they've all been linked to a toxic group of chemicals called phthalates that we're all exposed to every day. Phthalates are in everything from food packaging to personal care products to dental fillings. In fact, they're so common in our environment that they're sometimes called "everywhere chemicals." And like so many of the toxins in our environment, phthalates throw your hormones out of whack. They cause estrogen levels to soar in both men and women. Chemicals like these are...
Source: Al Sears, MD Natural Remedies - January 6, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Health Nutrition Source Type: news

Identifying Subtypes of Rheumatoid Arthritis Identifying Subtypes of Rheumatoid Arthritis
From the ACR meeting in Washington, DC, Dr Laura Donlin discusses her research exploring how subtyping rheumatoid arthritis could lead to more personalized treatment.Medscape Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 3, 2017 Category: Pathology Tags: Rheumatology Expert Interview Source Type: news

Why New Drug Approvals Are At A Six-Year Low In The U.S.
LONDON (Reuters) - Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on 2015’s tally of 45. Across the Atlantic, the European Medicines Agency recommended 81 new prescription products against a 2015 total of 93. Unlike the FDA, the EMA includes generic drugs in its list. The slowdown suggests the pharmaceuticals industry may be returning to more normal productivity levels after a spike in approvals in 2014 and 2015, when the haul of new drugs reaching the market hit a 1...
Source: Science - The Huffington Post - January 3, 2017 Category: Science Source Type: news

ICER issues draft report on rheumatoid arthritis treatments
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 31, 2016 Category: Drugs & Pharmacology Source Type: news

Coping with arthritis: What you do isn't associated with how much information you want
(Bentham Science Publishers) Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Carolina Eshelman School of Pharmacy. Study findings suggest that the attentional coping styles of patients with rheumatoid arthritis and osteoarthritis tend not to be associated with self-management behaviors such as how often patients have medication related discussions with their doctors and medication adherence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 29, 2016 Category: Global & Universal Source Type: news

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Science - The Huffington Post - December 28, 2016 Category: Science Source Type: news

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Healthy Living - The Huffington Post - December 28, 2016 Category: Consumer Health News Source Type: news

Biomarkers Predict Rituximab Response in RA (CME/CE)
(MedPage Today) -- ' A further step towards the goal of personalized medicine ' in rheumatoid arthritis (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - December 28, 2016 Category: Geriatrics Source Type: news

What is rheumatoid arthritis? Chronic condition is caused by your OWN immune system
RHEUMATOID arthritis is a long-term condition that causes pain, swelling and stiffness in the joints and mainly affects the hands feet and wrists. (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2016 Category: Consumer Health News Source Type: news

Migraine drugs may repeat rheumatoid arthritis success
(Reuters) - Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder. (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Olumiant (baricitinib) Oral Treatment for Rheumatoid Arthritis
Information regarding Olumiant (baricitinib) for the treatment of adults with moderate to severe active rheumatoid arthritis (Source: Disabled World)
Source: Disabled World - December 22, 2016 Category: Disability Tags: Pharmaceutical - Drug Information Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Science - The Huffington Post - December 21, 2016 Category: Science Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Healthy Living - The Huffington Post - December 21, 2016 Category: Consumer Health News Source Type: news

CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More
The EMA ' s CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - December 19, 2016 Category: Nursing Tags: Rheumatology News Alert Source Type: news

Discovery's Edge: Linking gut bacteria to Rheumatoid Arthritis
The cause of rheumatoid arthritis, a systemic autoimmune disease, is unknown. But certain genes and environmental factors, such as smoking, are linked to the disease process. Now Mayo Clinic research suggests a new link: the composition of gut microbes. Veena Taneja, Ph.D., an immunologist at Mayo Clinic?s Center for Individualized Medicine, recently demonstrated a relationship [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 19, 2016 Category: Databases & Libraries Source Type: news

Gum disease bug linked to rheumatoid arthritis
Conclusions This research aimed to investigate a possible bacterial origin of rheumatoid arthritis and found one potential candidate – Aggregatibacter actinomycetemcomitans (Aα). It seems these bacteria could cause the high levels of citrullinated proteins which are known to trigger an immune reaction in people with rheumatoid arthritis. However, it's important to put these findings into the right context. Though antibodies against citrullinated proteins, anti-cyclic citrullinated peptide (anti-CCP), are one of the possible diagnostic findings in people with rheumatoid arthritis – not everyone with rheumatoid arthri...
Source: NHS News Feed - December 19, 2016 Category: Consumer Health News Tags: Medical practice Source Type: news

CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis
The EMA ' s CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 16, 2016 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Brushing your teeth could prevent arthritis, experts say
The discovery by researchers at Johns Hopkins University adds to evidence that rheumatoid arthritis is linked with dental health, a theory that has been suspected for a long time. (Source: the Mail online | Health)
Source: the Mail online | Health - December 16, 2016 Category: Consumer Health News Source Type: news

Brush teeth to beat Arthritis: Bugs that cause gum disease linked to rheumatoid arthritis
BRUSHING your teeth could help ward off the agony of rheumatoid arthritis, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - December 16, 2016 Category: Consumer Health News Source Type: news